| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |